Материал: БА КР 2019

66

84.Basheti IA, Reddel HK, Armour CL, Bosnic-Anticevich SZ. Improved asthma outcomes with a simple inhaler technique intervention by community pharmacists. J Allergy Clin Immunol 2007;119:1537-8.

85.Honkoop PJ, Loymans R JB, Termeer EH, Snoeck-Stroband JB, Bakker MJ et al. Asthma control cost-utility randomized trial evaluation (ACCURATE): the goals of asthma treatment. BMC Pulm Med. 2011;11:53.

86.Castro-Rodriguez JA, Rodrigo GJ. Beta-agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with metaanalysis. J Pediatr 2004;145:172-7.

87.Abramson MJ, Puy RM, Weiner JM. Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev 2010: CD001186

88.Tao L, Shi B, Shi G, Wan H. Efficacy of sublingual immunotherapy for allergic asthma: retrospective meta-analysis of randomized, double-blind and placebocontrolled trials. Clin Respir J 2014;8:192-205.

89.Virchow JC, Backer V, Kuna P et al. Efficacy of a house dust mite sublingualallergen immunotherapy tablet in adults with allergic asthma: A randomized clinical trial. Jama 2016;315:1715-25.

90.Mosbech H, Deckelmann R, de Blay F et al. Standardized quality (SQ) house dust mite sublingualimmunotherapy tablet (ALK) reduces inhaled cprticosteroid use while maintainingasthma control: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2014;134:568-75.

91.Hondras MA, Linde K, Jones AP. Manual therapy for asthma. Cochrane database Syst Rev 2005(2):CD001002.

92.Global Strategy for Asthma Management and Prevention. Revised 2006 // www.ginasthma.com.

93.Cooper S, Oborne J, Newton S, Harrison V, Thompson C et al. Effect of two breathing exercises (Buteyko and pranayama) in asthma: a randomized controlled trial. Thorax. 2003; 58 (8): 674-679.

94.Rodrigo GJ, Castro-Rodriguez JA Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis // Thorax. 2005. V. 60. P.740-746.

66

67

95.Camargo CA Jr, Spooner CH, Rowe BH. Continuous versus intermittent beta-agonists in the treatment of acute asthma. Cochrane Database Syst Rev. 2003;(4):CD001115.

96.Cates CJ, Welsh EJ, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2013.

97.Rodrigo GJ, Rodrigo C, Hall JB. Acute asthma in adults: a review. Chest 2004;125:1081-102.

98.Hasegawa T, Ishihara K, Takakura S, et al. Duration of systemic corticosteroids in the treatment of asthma exacerbation; a randomized study. Intern Med 2000;39:794-7.

99.Jones AM, Munavvar M, Vail A, et al. Prospective, placebo-controlled trial of 5 vs 10 days of oral prednisolone in acute adult asthma. Respir Med 2002;96:950-4.

100.Chien JW, Ciufo R, Novak R, et al. Uncontrolled oxygen administration and respiratory failure in acute asthma. Chest 2000;117:728-33.

101.Rodrigo GJ, Rodriquez Verde M, Peregalli V, Rodrigo C. Effects of short-term 28% and 100% oxygen on PaCO2 and peak expiratory flow rate in acute asthma: a randomized trial. Chest 2003;124:1312-7.

102.Perrin K, Wijesinghe M, Healy B, et al. Randomised controlled trial of high concentration versus titrated oxygen therapy in severe exacerbations of asthma. Thorax 2011;66:937-41

103.Edmonds ML, Milan SJ, Camargo CA, Jr., Pollack CV, Rowe BH. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev 2012;12:CD002308.

104.Nair P, Milan SJ, Rowe BH. Addition of intravenous aminophylline to inhaled beta(2)-agonists in adults with acute asthma. Cochrane Database Syst Rev 2012;12:CD002742.

105.Ayres JG Classification and management of brittle asthma. Br J Hosp Med 1997;57:387-9.

106.Kolbe J, Fergusson W, Garrett J Rapid onset asthma: a severe but uncommon manifestation. Thorax 1998;53:241-7.

107.Rowe BH, Bretzlaff JA, Bourdon C, Bota GW, Camargo CA, Jr. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev 2000;2.

108.FitzGerald JM. Magnesium sulfate is effective for severe acute asthma treated in the emergency department. West J Med 2000;172:96.

67

68

109.Gallegos-Solorzano MC, Perez-Padilla R, Hernandez-Zenteno RJ. Usefulness of inhaled magnesium sulfate in the coadjuvant management of severe asthma crisis in an emergency department. Pulm Pharmacol Ther 2010;23:432-7.

110.Rodrigo GJ, Castro-Rodriguez JA. Heliox-driven beta2-agonists nebulization for children and adults with acute asthma: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 2014;112:29-34.

111.Silverman RA, Nowak RM, Korenblat PE, et al. Zafirlukast treatment for acute asthma: evaluation in a randomized, doubleblind, multicenter trial. Chest 2004;126:1480-9.

112.Ramsay CF, Pearson D, Mildenhall S, Wilson AM. Oral montelukast in acute asthma exacerbations: a randomised, doubleblind, placebo-controlled trial. Thorax 2011;66:7-11.

113.Lim WJ, Mohammed Akram R, Carson KV, et al. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database Syst Rev 2012;12:CD004360.

114.Soroksky, A. A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack. Chest. 2003; 123: 1018–1025

115.Gupta, D. A prospective randomized controlled trial on the efficacy of noninvasive ventilation in severe acute asthma. Respir Care. 2010; 55: 536–543

116.Georgopoulos D, Burchardi H. Ventilation strategies in adult patients with status asthmaticus. Eur Respir Mon 1998;3:45-83

117.Авдеев С.Н. Респираторная поддержка при астматическом статусе. Клинические рекоммендации. Бронхиальная астма у взрослых / Под ред. А.Г.Чучалина. М.:Атмосфера, 2002: 130-155.

118.Kuyper LM, Pare PD, Hogg JC, Lambert RK, Lonescu D et al. Characterization of airway plugging in fatal asthma. Am J Med. 2003;115(1):6-11.

119.National Asthma Education and Prevebtion Program. Expert Panel Report 3: Guidelines for the diagnosis and management of asthma. Clinical practice Guidelines. 2007. Report No.: 07-4051.

120.Grunfeld A, FitzGerald J. Discharge considerations for adult asthmatic patients treated in emergency departments. Can Respir J 1996;3:322-7.

121.McCarren M, Zalenski RJ, McDermott M, Kaur K. Predicting recovery from acute asthma in an emergency diagnostic and treatment unit. Acad Emerg Med.

2000;7(1):28-35

68

69

122.Edmonds ML, Camargo CA Jr, Saunders LD, Brenner BE, Rowe BH. Inhaled steroids in acute asthma following emergency department discharge. Cochrane Database Syst Rev. 2000 (3):CD002316.

123.Rowe BH, Bota GW, Fabris L, Therrien SA, Milner RA, JaconoJ. Inhaled budesonide in addition to oral steroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial. JAMA. 1999;281(22):2219-26.

124.Schatz M, Rachelefsky G, Krishnan JA. Follow-up after acute asthma episodes: what improves future outcomes? Proc Am Thorac Soc 2009;6:386-93.

125.Wilson NM, Silverman M. Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home. Arch Dis Child 1990;65:407-10.

126.Su XM, Yu N, Kong LF, Kang J. Effectiveness of inhaled corticosteroids in the treatment of acute asthma in children in the emergency department: a meta-analysis. Ann Med. 2014;46:24-30

127.Beckhaus AA, Riutort MC, Castro-Rodriguez JA. Inhaled versus systemic corticosteroids for acute asthma in children. A systematic review. Pediatr Pulmonol.2014;49:326-34.

128.Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev 2001:CD002178.

129.Yung M, South M. Randomised controlled trial of aminophylline for severe acute asthma. Arch Dis Child. 1998;79(5):405-10.

130.Griffiths B, Ducharme FM. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev 2013;8:CD000060.

131.Deerojanawong J, Manuyakorn W, Prapphal N, Harnruthakorn C, Sritippayawan S, Samransamruajkit R. Randomized controlled trial of salbutamol aerosol therapy via metered dose inhaler-spacer vs. jet nebulizer in young children with wheezing. Pediatr Pulmonol 2005;39:466-72.

132.Abramson MJ, Walters J, Walters EH Adverse effects of beta-agonists: are they clinically relevant? Am J Respir Med 2003;2(4):287-97

69

70

133.Razi CH, Akelma AZ, Harmanci K, Kocak M, Kuras Can Y. The additionof inhaled budesonide to standard therapy shortens the lenghth of stay in hospital for asthmatic preschool children: A randomized, double-blind, placebo-controlled trial. Int Arch Allergy Immunol 2015;166:297-303.

134.Gamble J, Stevenson M, Heaney LG. A study of a multi-level intervention to improve non-adherence in difficult to control asthma. Respir Med 2011;105:1308-15.

135.Wenzel S. Severe asthma in adults. Am J Respir Crit Care Med 2005;172:149-60.

136.Petsky HL, Cates CJ, Lasserson TJ, et al. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Thorax 2012;67:199-208.

137.Murphy VE, Gibson PG. Asthma in pregnancy. Clin Chest Med 2011;32:93-110,

ix.

138.Zacharasiewicz A. Maternal smoking in pregnancy and its influence on childhood asthma. ERJ Open Res. 2016 Jul: 2(3): 00042-2016.

139.Lim A, Stewart K, Konig K, George J. Systematic review of the safety of regular preventive asthma medications during pregnancy. Ann Pharmacother 2011;45:931-45.

140.NAEPP Expert Panel Report. Managing asthma during pregnancy: recommendations for pharmacologic treatment – 2004 update. // J Allergy Clin Immunol. – 2005 Vol. 115 N 1 P. 34 – 46.

141.Wendel PJ, Ramin SM, Barnett-Hamm C et al. Asthma treatment in pregnancy: a randomized controlled study. Am J Obstet Gynecol 1996;175:150-4.

142.Dombrowski MP, Schatz M, Wise R, Momirova V, Landon M et al. Asthma during pregnancy. Obstet. Gynecol. 2004. Vol. 103. N 1 P. 5-12.

143.Giles W., Murphy V. Asthma in pregnancy: a review. Obstet Med. 2013 Jun; 6(2): 58-63.

144.Michaud P-A, Suris JC, Viner R. The adolescent with a chronic condition : epidemiology, developmental issues and health care provision. Geneva: WHO; 2007.

145.Baur X, Sigsgaard T, Aasen TB, et al. Guidelines for the management of workrelated asthma. [Erratum appears in Eur Respir J. 2012 Jun;39(6):1553]. Eur Respir J 2012;39:529-45.

146.Malo JL, Cote J, Cartier A et al. How many times per day should peak expiratory flow rates be assessed when investigating occupational asthma? Thorax 1993;48:1211-17.

70